KUNAL MAHENDRA BHAKTA's Insider Trades & SAST Disclosures
KUNAL MAHENDRA BHAKTA's most recent trade in Balaxi Pharmaceuticals Ltd. was a Buy of 2,297 Equity Shares done at an average price of Rs. 621.9 . Disclosure was reported to the exchange on Feb. 13, 2021 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for KUNAL MAHENDRA BHAKTA in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 13 Feb 2021 | 2,297 | 2,297 | - | 621.9 | 1,428,437 | 04 Feb 2021 11 Feb 2021 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 09 Mar 2021 | 2,302 | 4,599 | - | 616.6 | 1,419,452 | 12 Feb 2021 08 Mar 2021 |
Insider Trading (-) | Equity Shares | Market Purchase |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 13 Oct 2022 | 200,000 | 200,000 (0%) | - | 112.8 | 22,550,000 | 11 Oct 2022 11 Oct 2022 |
Insider Trading (-) | Warrants | Preferential Offer |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Sell | 26 Jan 2024 | 67,000 | 133,000 (0%) | - | 338.3 | 22,662,750 | 25 Jan 2024 25 Jan 2024 |
Insider Trading (-) | Warrants | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 26 Jan 2024 | 67,000 | 72,771 | - | 338.3 | 22,662,750 | 25 Jan 2024 25 Jan 2024 |
Insider Trading (-) | Equity Shares | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Sell | 27 Feb 2024 | 67,000 | 66,000 (0%) | - | 338.3 | 22,662,750 | 23 Feb 2024 23 Feb 2024 |
Insider Trading (-) | Warrants | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 27 Feb 2024 | 67,000 | 139,771 | - | 338.3 | 22,662,750 | 23 Feb 2024 23 Feb 2024 |
Insider Trading (-) | Equity Shares | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 18 Mar 2024 | 16,000 | 155,771 | - | 338.3 | 5,412,000 | 15 Mar 2024 15 Mar 2024 |
Insider Trading (-) | Equity Shares | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Sell | 18 Mar 2024 | 16,000 | 50,000 (0%) | - | 338.3 | 5,412,000 | 15 Mar 2024 15 Mar 2024 |
Insider Trading (-) | Warrants | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Sell | 15 Apr 2024 | 50,000 | - (0%) | - | 338.3 | 16,912,500 | 11 Apr 2024 11 Apr 2024 |
Insider Trading (-) | Warrants | Conversion of security |
| Balaxi Pharma | KUNAL MAHENDRA BHAKTA | Director | Buy | 15 Apr 2024 | 50,000 | 205,771 | - | 338.3 | 16,912,500 | 11 Apr 2024 11 Apr 2024 |
Insider Trading (-) | Equity Shares | Conversion of security |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.